Kavaliauskiene S, Nymark C, Bergan J, Simm R, Sylvanne T, Simolin H
Cell Mol Life Sci. 2013; 71(6):1097-116.
PMID: 23921715
PMC: 11113877.
DOI: 10.1007/s00018-013-1441-y.
Hotz B, Backer M, Backer J, Buhr H, Hotz H
Neoplasia. 2010; 12(10):797-806.
PMID: 20927318
PMC: 2950329.
DOI: 10.1593/neo.10418.
Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T
Infect Immun. 2005; 73(12):8306-16.
PMID: 16299328
PMC: 1307066.
DOI: 10.1128/IAI.73.12.8306-8316.2005.
Durkan A, Menascu S, Langlois V
Pediatr Nephrol. 2004; 19(8):915-6.
PMID: 15185136
DOI: 10.1007/s00467-004-1515-z.
Acheson D, MOORE R, De Breucker S, Lincicome L, Jacewicz M, Skutelsky E
Infect Immun. 1996; 64(8):3294-300.
PMID: 8757867
PMC: 174221.
DOI: 10.1128/iai.64.8.3294-3300.1996.
The shigella paradigm and colitis due to enterohaemorrhagic Escherichia coli.
Acheson D, Keusch G
Gut. 1994; 35(7):872-4.
PMID: 8063211
PMC: 1374830.
DOI: 10.1136/gut.35.7.872.
Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome.
OBrien J, van Why S, Keller M, Gaudio K, Kennedy T, Siegel N
Yale J Biol Med. 1994; 67(1-2):1-14.
PMID: 7645308
PMC: 2590798.
Causes of the haemolytic uraemic syndrome.
Kavi J, Wise R
BMJ. 1989; 298(6666):65-6.
PMID: 2493295
PMC: 1835439.
DOI: 10.1136/bmj.298.6666.65.
Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.
Waddell T, Cohen A, Lingwood C
Proc Natl Acad Sci U S A. 1990; 87(20):7898-901.
PMID: 2236008
PMC: 54858.
DOI: 10.1073/pnas.87.20.7898.
Glomerular fibrin deposition and removal.
Bergstein J
Pediatr Nephrol. 1990; 4(1):78-87.
PMID: 2206888
DOI: 10.1007/BF00858447.
Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.
Kaplan B, Cleary T, Obrig T
Pediatr Nephrol. 1990; 4(3):276-83.
PMID: 2205273
DOI: 10.1007/BF00857676.
New insights into the haemolytic uraemic syndromes.
Milford D, Taylor C
Arch Dis Child. 1990; 65(7):713-5.
PMID: 2201260
PMC: 1792434.
DOI: 10.1136/adc.65.7.713.
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
Louise C, Obrig T
Infect Immun. 1991; 59(11):4173-9.
PMID: 1937774
PMC: 259013.
DOI: 10.1128/iai.59.11.4173-4179.1991.
Haemolytic-uraemic syndrome associated with Aeromonas hydrophila enterocolitis.
Bogdanovic R, Cobeljic M, Markovic M, Nikolic V, Ognjanovic M, Sarjanovic L
Pediatr Nephrol. 1991; 5(3):293-5.
PMID: 1867983
DOI: 10.1007/BF00867480.
Current views on aetiology and management of haemolytic uraemic syndrome.
Fitzpatrick M, Dillon M
Postgrad Med J. 1991; 67(790):707-9.
PMID: 1754520
PMC: 2399050.
DOI: 10.1136/pgmj.67.790.707.
